PolyPeptide Group AG (PLYGF OTCQB) stock market data APIs
$53.979
0(0%)
as of September 11, 2026
Try our APIs with
free plan!
PolyPeptide Group AG Financial Data Overview
Price chart is built with
Anychart
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Prev. Close
53.979
Open
53.979
High
53.979
Low
53.979
52 wk Range
43-54.42
Market Cap
1 797 M
P/E Ratio
106.7059
Shares Outstanding
33 016 K
Revenue
459 M
Beta
1.002
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PolyPeptide Group AG data using free add-ons & libraries
Get PolyPeptide Group AG Fundamental Data
PolyPeptide Group AG Fundamental data includes:
- Net Revenue: 459 M
- EBITDA: 75 454 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PolyPeptide Group AG News
New
PolyPeptide Draws EQT, IDG Interest In $1.6 Billion Takeover Push
This article first appeared on GuruFocus. PolyPeptide Group AG (PLYGF) is moving deeper into the takeover spotlight, with private equity firms EQT AB (EQBBF) and IDG Capital shortlisted for the next ...
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
[FDA Headquarters] The U.S. Food and Drug Administration (FDA) on Wednesday convened a group of independent advisors to recommend whether to allow compounding pharmacies to manufacture certain peptid...
PolyPeptide Draws Buyout Interest as Turnaround Gains Credibility
PolyPeptide Draws Buyout Interest as Turnaround Gains Credibility - Moby THE GIST PolyPeptide’s rally isn’t just about better numbers — it’s about a shift in perception. A once messy turnaro...
PolyPeptide Reports Strong Preliminary 2025 Results With Higher Revenue And Profit
(RTTNews) - PolyPeptide Group AG (PPGN.SW) on Monday reported preliminary results for the 2025 financial year, showing higher revenue and improved profitability compared with 2024. The company generat...
Get PolyPeptide Group AG fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
